Filter

Refine by collections

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 21 - 30 of 174 items for :

  • "thyroid cancer" x
Clear All
Maria Luisa Garo Mathsly Research, Roma, Italy

Search for other papers by Maria Luisa Garo in
Google Scholar
PubMed Close
,
Désirée Deandreis Division of Nuclear Medicine, Department of Medical Sciences, AOU Città della Salute e della Scienza, University of Turin, Turin, Italy

Search for other papers by Désirée Deandreis in
Google Scholar
PubMed Close
,
Alfredo Campennì Nuclear Medicine Unit, Department of Biomedical and Dental Sciences and Morpho-Functional Imaging, University of Messina, Messina, Italy

Search for other papers by Alfredo Campennì in
Google Scholar
PubMed Close
,
Alexis Vrachimis Department of Nuclear Medicine, German Oncology Center, University Hospital of the European University, Limassol, Cyprus

Search for other papers by Alexis Vrachimis in
Google Scholar
PubMed Close
,
Petra Petranovic Ovcaricek Department of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, Zagreb, Croatia

Search for other papers by Petra Petranovic Ovcaricek in
Google Scholar
PubMed Close
, and
Luca Giovanella Clinic for Nuclear Medicine and Molecular Imaging, Imaging Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland
Clinic for Nuclear Medicine, University Hospital of Zürich, Zürich, Switzerland

Search for other papers by Luca Giovanella in
Google Scholar
PubMed Close

Introduction Differentiated thyroid cancer (DTC) accounts for 90% of all thyroid cancers and is increasing threefold every decade ( 1 ) so that by 2040 it will be the fourth most common malignancy in the group aged 20–49 years ( 2 ). Papillary

Article Type:
Research Article
Collections:
Thyroid
DOI:
https://doi.org/10.1530/EC-22-0457
Volume/Issue:
Volume 12: Issue 4
Open access
Wei Li Department of Nuclear Medicine, Tianjin Medical University General Hospital, Tianjin, People’s Republic of China

Search for other papers by Wei Li in
Google Scholar
PubMed Close
,
Qing Huang Collage of Tourism and Service Management, Nankai University, Tianjin, People’s Republic of China

Search for other papers by Qing Huang in
Google Scholar
PubMed Close
,
Danyang Sun Department of Nuclear Medicine, Tianjin Medical University General Hospital, Tianjin, People’s Republic of China

Search for other papers by Danyang Sun in
Google Scholar
PubMed Close
,
Guizhi Zhang Department of Nuclear Medicine, Tianjin Medical University General Hospital, Tianjin, People’s Republic of China

Search for other papers by Guizhi Zhang in
Google Scholar
PubMed Close
, and
Jian Tan Department of Nuclear Medicine, Tianjin Medical University General Hospital, Tianjin, People’s Republic of China

Search for other papers by Jian Tan in
Google Scholar
PubMed Close

Introduction Papillary thyroid carcinoma (PTC) is the most common subtype of thyroid cancer. In 2008, the incidence of thyroid cancer was 1.4/100,000, and it accounts for 0.8% of all malignancies in China (0.4% of those in men, 1.3% in women

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-17-0209
Volume/Issue:
Volume 6: Issue 8
Open access
Ashley N Reeb Department of Otolaryngology, Head and Neck Surgery, Saint Louis University School of Medicine, Saint Louis, Missouri, USA

Search for other papers by Ashley N Reeb in
Google Scholar
PubMed Close
,
Andrea Ziegler Department of Otolaryngology, Head and Neck Surgery, Saint Louis University School of Medicine, Saint Louis, Missouri, USA

Search for other papers by Andrea Ziegler in
Google Scholar
PubMed Close
, and
Reigh-Yi Lin Department of Otolaryngology, Head and Neck Surgery, Saint Louis University School of Medicine, Saint Louis, Missouri, USA

Search for other papers by Reigh-Yi Lin in
Google Scholar
PubMed Close

Introduction Follicular thyroid cancer (FTC) is the second most frequently diagnosed thyroid cancer after papillary thyroid cancer (PTC). About 10,000 cases of FTC are diagnosed annually in the United States, comprising about 10–15% of all

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-15-0114
Volume/Issue:
Volume 5: Issue 2
Open access
Danuta Gąsior-Perczak Endocrinology Clinic, Holycross Cancer Centre, Kielce, Poland

Search for other papers by Danuta Gąsior-Perczak in
Google Scholar
PubMed Close
,
Iwona Pałyga Endocrinology Clinic, Holycross Cancer Centre, Kielce, Poland

Search for other papers by Iwona Pałyga in
Google Scholar
PubMed Close
,
Monika Szymonek Endocrinology Clinic, Holycross Cancer Centre, Kielce, Poland

Search for other papers by Monika Szymonek in
Google Scholar
PubMed Close
,
Artur Kowalik Department of Molecular Diagnostics, Holycross Cancer Centre, Kielce, Poland

Search for other papers by Artur Kowalik in
Google Scholar
PubMed Close
,
Agnieszka Walczyk Endocrinology Clinic, Holycross Cancer Centre, Kielce, Poland

Search for other papers by Agnieszka Walczyk in
Google Scholar
PubMed Close
,
Janusz Kopczyński Department of Surgical Pathology, Holycross Cancer Centre, Kielce, Poland

Search for other papers by Janusz Kopczyński in
Google Scholar
PubMed Close
,
Katarzyna Lizis-Kolus Endocrinology Clinic, Holycross Cancer Centre, Kielce, Poland

Search for other papers by Katarzyna Lizis-Kolus in
Google Scholar
PubMed Close
,
Anna Słuszniak Laboratory of Tumor Markers, Holycross Cancer Centre, Kielce, Poland

Search for other papers by Anna Słuszniak in
Google Scholar
PubMed Close
,
Janusz Słuszniak Department of Surgical Oncology, Holycross Cancer Centre, Kielce, Poland

Search for other papers by Janusz Słuszniak in
Google Scholar
PubMed Close
,
Tomasz Łopatyński Department of Surgery, Oncology Center of Lublin Land, Lublin, Poland

Search for other papers by Tomasz Łopatyński in
Google Scholar
PubMed Close
,
Ryszard Mężyk Cancer Epidemiology, Holycross Cancer Centre, Kielce, Poland

Search for other papers by Ryszard Mężyk in
Google Scholar
PubMed Close
,
Stanisław Góźdź Oncology Clinic, Holycross Cancer Centre, Kielce, Poland
The Faculty of Health Sciences, Jan Kochanowski University, Kielce, Poland

Search for other papers by Stanisław Góźdź in
Google Scholar
PubMed Close
, and
Aldona Kowalska Endocrinology Clinic, Holycross Cancer Centre, Kielce, Poland
The Faculty of Health Sciences, Jan Kochanowski University, Kielce, Poland

Search for other papers by Aldona Kowalska in
Google Scholar
PubMed Close

Introduction Increased access to imaging techniques and fine-needle aspiration cytology (FNAC) has resulted in an increase in the rate of detection of differentiated thyroid cancer (DTC) in recent years ( 1 , 2 , 3 , 4 ). The increase in

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-17-0135
Volume/Issue:
Volume 6: Issue 7
Open access
Thera P Links Division of Endocrinology, Department of Internal Medicine, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands

Search for other papers by Thera P Links in
Google Scholar
PubMed Close
,
Trynke van der Boom Division of Endocrinology, Department of Internal Medicine, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands

Search for other papers by Trynke van der Boom in
Google Scholar
PubMed Close
,
Wouter T Zandee Division of Endocrinology, Department of Internal Medicine, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands

Search for other papers by Wouter T Zandee in
Google Scholar
PubMed Close
, and
Joop D Lefrandt Division of Vascular Medicine, Department of Internal Medicine, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands

Search for other papers by Joop D Lefrandt in
Google Scholar
PubMed Close

the impact of overt and subclinical hyperthyroidism on the cardiovascular system. We will thereafter present the latest insights on the cardiac effects of thyroid suppression therapy for the treatment of thyroid cancer. Finally, we will show new

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EC-20-0539
Volume/Issue:
Volume 10: Issue 1
Open access
Wei Sun Department of Thyroid Surgery, The First Hospital of China Medical University, Shenyang, Liaoning Province, China

Search for other papers by Wei Sun in
Google Scholar
PubMed Close
,
Boyuan Zheng Department of Thyroid Surgery, The First Hospital of China Medical University, Shenyang, Liaoning Province, China

Search for other papers by Boyuan Zheng in
Google Scholar
PubMed Close
,
Zhihong Wang Department of Thyroid Surgery, The First Hospital of China Medical University, Shenyang, Liaoning Province, China

Search for other papers by Zhihong Wang in
Google Scholar
PubMed Close
,
Wenwu Dong Department of Thyroid Surgery, The First Hospital of China Medical University, Shenyang, Liaoning Province, China

Search for other papers by Wenwu Dong in
Google Scholar
PubMed Close
,
Yuan Qin Department of Thyroid Surgery, The First Hospital of China Medical University, Shenyang, Liaoning Province, China

Search for other papers by Yuan Qin in
Google Scholar
PubMed Close
, and
Hao Zhang Department of Thyroid Surgery, The First Hospital of China Medical University, Shenyang, Liaoning Province, China

Search for other papers by Hao Zhang in
Google Scholar
PubMed Close

Introduction The most prevalent endocrine malignancy is thyroid cancer, which accounts for 1% of all malignancies. Recently, morbidity caused by thyroid cancer has increased by three-fold ( 1 , 2 ). Histologically, the most common type of

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-20-0058
Volume/Issue:
Volume 9: Issue 5
Open access
Susana Pastor Grup de Mutagènesi, CIBER Epidemiología y Salud Pública, Servei de Medicina Nuclear, Unidad de Endocrinología, Departament de Genètica i de Microbiologia, Facultat de Biociències, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès, Barcelona, Spain
Grup de Mutagènesi, CIBER Epidemiología y Salud Pública, Servei de Medicina Nuclear, Unidad de Endocrinología, Departament de Genètica i de Microbiologia, Facultat de Biociències, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès, Barcelona, Spain

Search for other papers by Susana Pastor in
Google Scholar
PubMed Close
,
Abdelmounaim Akdi Grup de Mutagènesi, CIBER Epidemiología y Salud Pública, Servei de Medicina Nuclear, Unidad de Endocrinología, Departament de Genètica i de Microbiologia, Facultat de Biociències, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès, Barcelona, Spain

Search for other papers by Abdelmounaim Akdi in
Google Scholar
PubMed Close
,
Eddy R González Grup de Mutagènesi, CIBER Epidemiología y Salud Pública, Servei de Medicina Nuclear, Unidad de Endocrinología, Departament de Genètica i de Microbiologia, Facultat de Biociències, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès, Barcelona, Spain

Search for other papers by Eddy R González in
Google Scholar
PubMed Close
,
Juan Castell Grup de Mutagènesi, CIBER Epidemiología y Salud Pública, Servei de Medicina Nuclear, Unidad de Endocrinología, Departament de Genètica i de Microbiologia, Facultat de Biociències, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès, Barcelona, Spain

Search for other papers by Juan Castell in
Google Scholar
PubMed Close
,
Josefina Biarnés Grup de Mutagènesi, CIBER Epidemiología y Salud Pública, Servei de Medicina Nuclear, Unidad de Endocrinología, Departament de Genètica i de Microbiologia, Facultat de Biociències, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès, Barcelona, Spain

Search for other papers by Josefina Biarnés in
Google Scholar
PubMed Close
,
Ricard Marcos Grup de Mutagènesi, CIBER Epidemiología y Salud Pública, Servei de Medicina Nuclear, Unidad de Endocrinología, Departament de Genètica i de Microbiologia, Facultat de Biociències, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès, Barcelona, Spain
Grup de Mutagènesi, CIBER Epidemiología y Salud Pública, Servei de Medicina Nuclear, Unidad de Endocrinología, Departament de Genètica i de Microbiologia, Facultat de Biociències, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès, Barcelona, Spain

Search for other papers by Ricard Marcos in
Google Scholar
PubMed Close
, and
Antonia Velázquez Grup de Mutagènesi, CIBER Epidemiología y Salud Pública, Servei de Medicina Nuclear, Unidad de Endocrinología, Departament de Genètica i de Microbiologia, Facultat de Biociències, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès, Barcelona, Spain
Grup de Mutagènesi, CIBER Epidemiología y Salud Pública, Servei de Medicina Nuclear, Unidad de Endocrinología, Departament de Genètica i de Microbiologia, Facultat de Biociències, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès, Barcelona, Spain

Search for other papers by Antonia Velázquez in
Google Scholar
PubMed Close

Introduction Thyroid cancer is of special concern in endocrinology practice, accounting for more than 90% of all endocrine cancers. Moreover, its incidence is increasing in developed countries (1, 2) . Differentiated thyroid carcinoma (DTC

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-12-0017
Volume/Issue:
Volume 1: Issue 2
Open access
Andrea Mazurat Section of Surgical Oncology, Department of Surgery, CancerCare Manitoba, University of Manitoba, GF440 A, 820 Sherbrook Street, Winnipeg, Manitoba, Canada R3A 1R9

Search for other papers by Andrea Mazurat in
Google Scholar
PubMed Close
,
Andrea Torroni Section of Surgical Oncology, Department of Surgery, CancerCare Manitoba, University of Manitoba, GF440 A, 820 Sherbrook Street, Winnipeg, Manitoba, Canada R3A 1R9

Search for other papers by Andrea Torroni in
Google Scholar
PubMed Close
,
Jane Hendrickson-Rebizant Section of Surgical Oncology, Department of Surgery, CancerCare Manitoba, University of Manitoba, GF440 A, 820 Sherbrook Street, Winnipeg, Manitoba, Canada R3A 1R9

Search for other papers by Jane Hendrickson-Rebizant in
Google Scholar
PubMed Close
,
Harbinder Benning Section of Surgical Oncology, Department of Surgery, CancerCare Manitoba, University of Manitoba, GF440 A, 820 Sherbrook Street, Winnipeg, Manitoba, Canada R3A 1R9

Search for other papers by Harbinder Benning in
Google Scholar
PubMed Close
,
Richard W Nason Section of Surgical Oncology, Department of Surgery, CancerCare Manitoba, University of Manitoba, GF440 A, 820 Sherbrook Street, Winnipeg, Manitoba, Canada R3A 1R9

Search for other papers by Richard W Nason in
Google Scholar
PubMed Close
, and
K Alok Pathak Section of Surgical Oncology, Department of Surgery, CancerCare Manitoba, University of Manitoba, GF440 A, 820 Sherbrook Street, Winnipeg, Manitoba, Canada R3A 1R9

Search for other papers by K Alok Pathak in
Google Scholar
PubMed Close

Introduction Well-differentiated thyroid carcinoma (WDTC) represents a group of thyroid cancers that are associated with increasing incidence and excellent posttreatment outcome (1) . This group comprises different histological types, the most

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-13-0056
Volume/Issue:
Volume 2: Issue 3
Open access
Giuseppe Lisco Interdisciplinary Department of Medicine, Section of Internal Medicine, Geriatrics, Endocrinology and Rare Diseases, School of Medicine, University of Bari “Aldo Moro”, Piazza Giulio Cesare, Bari, Italy

Search for other papers by Giuseppe Lisco in
Google Scholar
PubMed Close
,
Anna De Tullio Interdisciplinary Department of Medicine, Section of Internal Medicine, Geriatrics, Endocrinology and Rare Diseases, School of Medicine, University of Bari “Aldo Moro”, Piazza Giulio Cesare, Bari, Italy

Search for other papers by Anna De Tullio in
Google Scholar
PubMed Close
,
Olga Disoteo Diabetology Unit, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy

Search for other papers by Olga Disoteo in
Google Scholar
PubMed Close
,
Giuseppina Piazzolla Interdisciplinary Department of Medicine, Section of Internal Medicine, Geriatrics, Endocrinology and Rare Diseases, School of Medicine, University of Bari “Aldo Moro”, Piazza Giulio Cesare, Bari, Italy

Search for other papers by Giuseppina Piazzolla in
Google Scholar
PubMed Close
,
Edoardo Guastamacchia Interdisciplinary Department of Medicine, Section of Internal Medicine, Geriatrics, Endocrinology and Rare Diseases, School of Medicine, University of Bari “Aldo Moro”, Piazza Giulio Cesare, Bari, Italy

Search for other papers by Edoardo Guastamacchia in
Google Scholar
PubMed Close
,
Carlo Sabbà Interdisciplinary Department of Medicine, Section of Internal Medicine, Geriatrics, Endocrinology and Rare Diseases, School of Medicine, University of Bari “Aldo Moro”, Piazza Giulio Cesare, Bari, Italy

Search for other papers by Carlo Sabbà in
Google Scholar
PubMed Close
,
Vincenzo De Geronimo Unit of Endocrinology, Policlinico Morgagni CCD, Catania, Italy

Search for other papers by Vincenzo De Geronimo in
Google Scholar
PubMed Close
,
Enrico Papini Department of Endocrinology and Metabolism, Regina Apostolorum Hospital, Rome, Italy

Search for other papers by Enrico Papini in
Google Scholar
PubMed Close
, and
Vincenzo Triggiani Interdisciplinary Department of Medicine, Section of Internal Medicine, Geriatrics, Endocrinology and Rare Diseases, School of Medicine, University of Bari “Aldo Moro”, Piazza Giulio Cesare, Bari, Italy

Search for other papers by Vincenzo Triggiani in
Google Scholar
PubMed Close

. Adequate hydration and fiber consumption, cessation of alcoholic beverage consumption, and eating lighter and smaller meals can be useful advice ( 6 ). The association between chronic exposure to GLP-1RAs and the new onset of thyroid cancer is a growing

Article Type:
Review Article
Collections:
Thyroid
DOI:
https://doi.org/10.1530/EC-23-0257
Volume/Issue:
Volume 12: Issue 11
Open access
Zuyao Chen The First Affiliated Hospital, Institute of Clinical Medicine, Hengyang Medical School, University of South China, Hengyang, Hunan, China
The First Affiliated Hospital, Department of Otorhinolaryngology, Hengyang Medical School, University of South China, Hengyang, Hunan, China

Search for other papers by Zuyao Chen in
Google Scholar
PubMed Close
,
Xiaolin Zhong The First Affiliated Hospital, Institute of Clinical Medicine, Hengyang Medical School, University of South China, Hengyang, Hunan, China
The First Affiliated Hospital, Department of Endocrinology and Metabolism, Hengyang Medical School, University of South China, Hengyang, Hunan, China

Search for other papers by Xiaolin Zhong in
Google Scholar
PubMed Close
,
Weiqiang Tang The First Affiliated Hospital, Institute of Clinical Medicine, Hengyang Medical School, University of South China, Hengyang, Hunan, China

Search for other papers by Weiqiang Tang in
Google Scholar
PubMed Close
,
Min Xia The First Affiliated Hospital, Institute of Clinical Medicine, Hengyang Medical School, University of South China, Hengyang, Hunan, China

Search for other papers by Min Xia in
Google Scholar
PubMed Close
,
Chang Liu Department of Endocrinology and Metabolism, The First People's Hospital of Chenzhou, Chenzhou, China

Search for other papers by Chang Liu in
Google Scholar
PubMed Close
,
Yinping Guo The First Affiliated Hospital, Institute of Clinical Medicine, Hengyang Medical School, University of South China, Hengyang, Hunan, China

Search for other papers by Yinping Guo in
Google Scholar
PubMed Close
,
Yan Yi The First Affiliated Hospital, Institute of Clinical Medicine, Hengyang Medical School, University of South China, Hengyang, Hunan, China

Search for other papers by Yan Yi in
Google Scholar
PubMed Close
,
Qingshan Jiang The First Affiliated Hospital, Department of Otorhinolaryngology, Hengyang Medical School, University of South China, Hengyang, Hunan, China

Search for other papers by Qingshan Jiang in
Google Scholar
PubMed Close
,
Xuyu Zu The First Affiliated Hospital, Institute of Clinical Medicine, Hengyang Medical School, University of South China, Hengyang, Hunan, China

Search for other papers by Xuyu Zu in
Google Scholar
PubMed Close
, and
Jing Zhong The First Affiliated Hospital, Institute of Clinical Medicine, Hengyang Medical School, University of South China, Hengyang, Hunan, China

Search for other papers by Jing Zhong in
Google Scholar
PubMed Close

-ori3-1 and thyroid cancer cells. (E-F) Representative immunohistochemistry images of FGF1-positive cells in PTC and ATC tissues and their adjacent normal tissues (Nor). Bar = 200 μm. ** P < 0.01 and *** P < 0.001. FGF1 promotes the

Article Type:
Research Article
Collections:
Thyroid
DOI:
https://doi.org/10.1530/EC-23-0014
Volume/Issue:
Volume 12: Issue 5
Open access